Successful treatment of a persistent mole with @entity3 by direct injection of XXXX .

@entity1 @entity5 @entity1469 @entity1475 @entity1500 @entity3 @entity1499
For @entity1 with persistent or invasive @entity1469 ( @entity1469 ), systemic injection of chemotherapy is the treatment of choice if fertility is to be preserved. To prevent serious adverse effects after systemic use and possibly achieve better effects, direct local injection of chemotherapy into the @entity5 site, especially when in the myometrium, seems a reasonable alternative. A @entity1 with a persistent @entity1475 with @entity3 is presented. A plateau of beta-hCG ( @entity1 chorionic gonadotropin) level around 550 mIU/mL was noticed for three weeks though systemic @entity1499 ( @entity1500 ) injection and repeat suction curettage had been performed. During the same period, a well-defined invasive complex with multiple vesicles in the myometrium was documented using transvaginal ultrasound (TVUS). Sonar-guided injection to the @entity5 using 50 mg @entity1500 was performed uneventfully. An obvious shrinkage of the mass and declining beta-hCG level were demonstrated after the procedure. The @entity1 restored her menses after the operation and a fertility evaluation including serial beta-hCG levels and hysterosalpingography showed them to be within the reference ranges. The successful outcome of this case encouraged us to treat localized invasive @entity1469 using direct injection of @entity1500 with the guidance of TVUS. Since no identical cases were found in our review of the English literature, more cases and similar regimens are needed to establish the safety and efficacy of this procedure.
